Emergent Biosolutions
EBS
EBS
208 hedge funds and large institutions have $1.17B invested in Emergent Biosolutions in 2016 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 76 increasing their positions, 67 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.15B → $1.17B (+$24.6M)
2.25% less ownership
Funds ownership: 90.5% → 88.25% (-2.2%)
Holders
208
Holding in Top 10
–
Calls
$1.32M
Puts
$804K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$12.2M | |
| 3 | +$9.91M | |
| 4 |
AAM
Aberdeen Asset Management
Aberdeen,
United Kingdom
|
+$8.3M |
| 5 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$6.15M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$10.2M | |
| 3 | -$9.67M | |
| 4 |
Goldman Sachs
New York
|
-$9.22M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.88M |